Transcription factor BACH2 is transcriptionally regulated by the BCR/ABL oncogene

Genes Chromosomes and Cancer

Volumn 32, Issue 4, 2001, Pages 353-363

  Vieira, Sara A D ^a   Deininger, Michael W N ^a   Sorour, Amani ^b   Sinclair, Paul ^b   Foroni, Letizia ^b   Goldman, John M ^a   Melo, Junia V ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; LEUCINE ZIPPER PROTEIN; MESSENGER RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR BACH2; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CHROMOSOME 6; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DNA BINDING; ENZYME INHIBITION; GENE DELETION; GENE MAPPING; GENE OVEREXPRESSION; GENE REPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; NUCLEOTIDE SEQUENCE; ONCOGENE; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN DOMAIN; SOUTHERN BLOTTING; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

ADULT; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 6; CLONING, MOLECULAR; EXONS; FUSION PROTEINS, BCR-ABL; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REARRANGEMENT; GENES, ABL; HELA CELLS; HL-60 CELLS; HUMANS; INTRONS; K562 CELLS; LEUKEMIA, MYELOID, CHRONIC; LYMPHOCYTES; LYMPHOPROLIFERATIVE DISORDERS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 0035163929     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.1200     Document Type: Article

References (43)

1. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma
2. Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative
3. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
4. Interleukin 3 protects murine bone marrow cells from apoptosis induced by DNA damaging agents
5. An optimized multiplex polymerase chain reaction (PCR) for detection of BCR-ABL fusion mRNAs in hematological disorders
6. The tyrosine kinase inhibitor CGP57148B selectively inhibits the growth of BCR-ABL positive cells
7. The molecular biology of chronic myeloid leukemia
8. BCR-ABL tyrosine kinase activity regulates the expression of multiple genes implicated in the pathogenesis of chronic myeloid leukemia
9. Effects of a selective inhibitor of the Abtyrosine kinase on the growth of Bcr-Abl positive cells
10. Activation of the P13′K-AKT pathway masks the proapoptotic effects of farnesyltransferase inhibitors
11. The role of cell cycle regulation and apoptosis triggering in determining the sensitivity of leukemi cells to topoisomerase I and II inhibitors
12. Frequent aberrant immunoglobulin gene rearrangements in pro-B cells revealed by a bcl-xL transgene
13. Inhibition of the ABL kinase activity blocks the proliferation of BCR/ABL+ leukemic cells and induces apoptosis
14. Localization by chromosome microdissection of a recurrent breakpoint region on chromosome 6 in human B-cell lymphoma
15. Analysis of clonal rearrangements of the Ig heavy chain locus in acute leukemia
16. Glucocorticoid-induced apoptosis of human leukemic cells is caused by the repressive function of the glucocorticoid receptor
17. Oxidative stress abolishes leptomycin B-sensitive nuclear export of transcription repressor Bach2 that counteracts activation of Maf recognition element
18. Deletion of in human lymphoid malignancies: A mapping and deletion analysis
19. Barx2, a new homeobox gene of the Bar class, is expressed in neural and craniofacial structures during development
20. A temperature sensitive p210 BCR-ABL mutant defines the primary consequences of BCR-ABL tyrosine kinase expression in growth factor dependent cells
21. Changes in the carbohydrate metabolism of mitogenically stimulated human peripheral lymphocytes. 3. Stimulation by tuberculin and allogenic cells
22. Tyrosine kinase activity and transformation potency of bcr-abl oncogene products
23. Selection and characterization of BCR-ABL positive cell lines with differential sensitivity to the tyrosine kinase inhibitor STI571: Diverse mechanisms of resistance
24. The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype
25. Deletion of a common region on the long arm of chromosome 6 in acute lymphoblastic leukaemia
26. Common region of deletion on the long arm of chromosome 6 in non-Hodgkin's lymphoma and acute lymphoblastic leukaemia
27. Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor
28. Identification of Bach2 as a B-cell-specific partner for small maf proteins that negatively regulate the immunoglobulin heavy chain gene 3′ enhancer
29. Functional expression of Fas antigen (CD95) on hematopoietic progenitor cells
30. Effect of farnesyltransferase overexpression on cell growth and transformation
31. The MAP kinase inhibitors. PD098059, UO126 and SB203580, inhibit IL-beta-dependent PGE(2) release via mechanistically distinct processes
32. Bach proteins belong to a novel family of BTB-basic leucine zipper transcription factors that interact with MafK and regulate transcription through the NF-E2 site
33. Lack of clonal BCRA2 gene deletion on chromosome 13 in chronic lymphocytic leukaemia
34. Reconstitution of a MEC1-independent checkpoint in yeast by expression of a novel human fork head cDNA
35. Cloning and expression of human B cell-specific transcription factor BACH2 mapped to chromosome 6q15
36. The BCR/ABL tyrosine kinase induces production of reactive oxygen species in hematopoietic cells
37. Signal transduction pathways involved in BCR-ABL transformation
38. Involvement of Fas-mediated apoptosis in the inhibitory effects of interferon-alpha in chronic myelogenous leukemia
39. Involvement of Fas-mediated apoptosis in the inhibitory effects of interferon-alpha in chronic myelogenous leukemia
40. Distinct mechanisms of STAT phosphorylation via the interferon-alpha/beta receptor. Selective inhibition of stat3 and stat5 by piceatannol
41. Establishment and molecular characterization of a novel leukemic cell line with Philadelphia chromosome expressing p230 BCR/ ABL fusion protein
42. Lymphocyte culture for chromosome analysis